News Detail
Mumbai, 17 June 2013: Another Indian pharma manufacturer is in trouble as Mumbai-based SyneCare's paracetamol suspension has been flagged as substandard. Nigeria's National Agency for Food and Drugs Ad......
View Details
View Details
Source : DrugsControl Media Services
Food and Drugs Administration and Control (NAFDAC)
NAFDAC
Para Clear Suspension 125
SynerCare's sample
toxic ethylene glycol
Related News
- Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)
- CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)
- India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)
- US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)
- Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)
- DCC recommends making Sugam portal database of all products with brand names (17-09-2024)
- CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)
- One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)
- Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)
- CDSCO to switch Form 44 submission online (16-09-2024)